Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Impact of CardiolRxTM on Recurrent Pericarditis

Patients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their

  • 0 views
  • 09 Apr, 2023
  • 5 locations
Dexamethasone Compared to Non-steroidal Anti-inflammatory Drugs in the Treatment of Acute Pericarditis

The treatment of acute pericarditis is empiric and is based on treatment with medications with anti-inflammatory properties such as non-steroidal anti-inflammatory drugs (NSAID) and

  • 2 views
  • 08 Oct, 2021
  • 1 location
Timing of Renal Replacement Therapy In Mechanically Ventilated Patients

This is a randomized controlled study that will be conducted on acute kidney injury (AKI) patients, who are mechanically ventilated, to assess the impact of implementation of early renal replacement therapy (RRT) compared to late RRT on patients outcome.

  • 0 views
  • 10 Sep, 2023
  • 1 location
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial fibrillation (AF). In this particular setting, balancing between the prevention of thrombosis and the risk of bleeding remains challenging. Oral anticoagulation (OAC) prevents stroke and …

unstable angina
embolism
anticoagulation therapy
arterial disease
fibrillation
  • 0 views
  • 12 Nov, 2021
  • 1 location
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis (IMPI-3)

The investigators hypothesise that high dose RIF (RIF35) will increase pericardial fluid RIF exposure and so enhance mycobacterial clearance, compared to standard of care dosing (RIF10). This Phase 2b randomized, placebo-controlled, double-blinded trial will evaluate the efficacy and safety of RIF 35mg/kg compared 10mg/kg, added to standard first-line ATT, for …

  • 0 views
  • 06 Jun, 2022
  • 1 location
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

/pericarditis Are capable of giving signed informed consent/assent (by parents/legal guardians of minors and/or patients), which includes compliance with the requirements and restrictions listed in

  • 0 views
  • 16 Sep, 2023
  • 21 locations
Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion and infarct size in patients with acute coronary syndrome.

angiography
chest pain
infarct
acute coronary syndrome
troponin
  • 0 views
  • 07 Oct, 2022
  • 1 location
Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation

Ablation of atrial fibrillation (AFib) has been recommended as a therapeutic option when rhythm maintenance strategy is sought. One of the main objectives of an AFib ablation procedure is electrical isolation of the pulmonary veins, which have been identified as common triggering sites of the arrhythmia. The pathophysiology of AFib …

fibrillation
arrhythmia
amiodarone
persistent atrial fibrillation
antiarrhythmic drug
  • 0 views
  • 04 Oct, 2022
  • 1 location
Supervised Exercise for Post-surgery Colorectal Cancer Patients (POSTEx)

Participants will undergo preoperative baseline screening and will be randomised to either normal postoperative care or a 12-week supervised exercise programme comprising of both an aerobic and resistance component They will be assessed prior to surgery which will include cardiopulmonary exercise testing (CPET). This is a well-established method of assessing …

  • 0 views
  • 31 Jul, 2023
  • 1 location
RiLuzole to Reduce Atrial FIb A Prospective, Double-Blind, Randomized, Placebo-Controlled Study Using Holter Monitoring (SOLUTION)

Atrial fibrillation (AF) is a growing clinical problem.1 AF is a highly dynamic condition involving episodes of sinus rhythm interspersed with periods of arrhythmia, becoming more difficult to terminate over time. AF carries a substantial cost, morbidity and mortality burden. There are two important approaches to the management of AF: …

  • 0 views
  • 07 Oct, 2022
  • 1 location